CREATIVE MEDICAL TECHNOLOGY (CELZ) Stock Analyst Earnings Estimates
NASDAQ:CELZ - Nasdaq - US22529Y4089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 90K -43.75% | 90K | 9K -90.00% | 8.16K -9.33% | -100.00% | 34.507M | 73.717M 113.63% | 92.846M 25.95% | 107.43M 15.71% | 118.91M 10.69% | ||
| EBITDA YoY % growth | -3.04M -192.31% | -10.15M -233.88% | -5.526M 45.56% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.13M -181.98% | -10.24M -227.16% | -5.62M 45.12% | -5.079M 9.64% | -4.683M 7.79% | -6.175M -31.87% | 17.746M 387.38% | 45.032M 153.76% | 58.256M 29.37% | 68.293M 17.23% | 76.157M 11.52% | |
| Operating Margin | -3,477.78% | -11,377.78% | -62,445.89% | -62,237.50% | N/A | N/A | 51.43% | 61.09% | 62.74% | 63.57% | 64.05% | |
| EPS YoY % growth | N/A | -9.80 -111.58% | -3.69 62.35% | -3.25 11.82% | -2.28 29.78% | -2.71 -18.75% | 3.33 222.56% | 6.47 94.48% | 8.19 26.66% | 9.40 14.82% | 10.26 9.11% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.64 46.00% | -0.65 10.58% | -0.55 50.38% | -0.55 26.56% | -0.55 14.29% |
| Revenue Q2Q % growth | -100.00% | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.143M 35.47% | -1.154M -2.71% | -1.165M 28.33% | -1.176M -5.98% | -1.188M -3.93% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.75 26.47% | -0.87 | 0.12 | 13.49% |
| Q2 2024 Q2Q % growth | -1.11 -42.31% | -0.86 | -0.25 | -29.55% |
| Q1 2024 Q2Q % growth | -0.73 -4.29% | -1.17 | 0.44 | 37.77% |
| Q4 2023 Q2Q % growth | -1.19 77.55% | -1.15 | -0.04 | -3.24% |
| Q3 2023 Q2Q % growth | -1.02 -45.71% | -0.88 | -0.14 | -16.28% |
| Q2 2023 Q2Q % growth | -0.78 61.00% | -0.85 | 0.07 | 7.87% |
| Q1 2023 Q2Q % growth | -0.70 61.11% | -1.02 | 0.32 | 31.37% |
| Q4 2022 Q2Q % growth | -5.30 87.26% | -0.71 | -4.59 | -642.30% |
| Q3 2022 Q2Q % growth | -0.70 | -1.33 | 0.63 | 47.21% |
| Q2 2022 Q2Q % growth | -2.00 | -1.53 | -0.47 | -30.72% |
| Q1 2022 Q2Q % growth | -1.80 | -1.43 | -0.37 | -26.05% |
| Q4 2021 Q2Q % growth | -41.60 | -2.35 | -39.25 | -1,673.23% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 3K -85.00% | 3K | % | |
| Q3 2023 Q2Q % growth | 6K -90.00% | 6K | % | |
| Q2 2023 Q2Q % growth | 15.3K | -15.3K | -100.00% | |
| Q1 2023 Q2Q % growth | -100.00% | 30.6K | -30.6K | -100.00% |
| Q4 2022 Q2Q % growth | 20K -71.43% | 369.24K | -349.24K | -94.58% |
| Q3 2022 Q2Q % growth | 60K 500.00% | 112.2K | -52.2K | -46.52% |
| Q2 2022 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2022 Q2Q % growth | 20K | 20.4K | -400 | -1.96% |
| Q4 2021 Q2Q % growth | 70K 250.00% | 10.2K | 59.8K | 586.27% |
| Q3 2021 Q2Q % growth | 10K -87.50% | % | ||
| Q2 2021 Q2Q % growth | 10K -66.67% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | 80K 33.33% | % | ||
| Q2 2020 Q2Q % growth | 30K -50.00% | % | ||
| Q1 2020 Q2Q % growth | 40K -20.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 47.06% | 0% | 3.04% |
| Revenue | N/A | N/A | 0% | N/A |